Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Other Issues:
Previous Next
  [Index by Author]
 
Contents: Volume 14, Issue 6
June 1, 1996
 

Down ARTICLES
Down SPECIAL DEPARTMENTS
  Down Erratum

Find articles in this issue containing these words:
[Search ALL Issues]


Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

 
ARTICLES Back
One hundred thirteen men with hormone-refractory prostate cancer died today
NJ Vogelzang
JCO Jun 1 1996: 1753–1755. [PDF]  
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points
  IF Tannock, D Osoba, MR Stockler, DS Ernst, AJ Neville, MJ Moore, GR Armitage, JJ Wilson, PM Venner, CM Coppin, and KC Murphy
  JCO Jun 1 1996: 1756–1764. [Abstract] [PDF]  
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis
  PC Brenner, HW Herr, MJ Morse, J Sheinfeld, A Aprikian, GJ Bosl, RJ Motzer, DF Bajorin, S Schantz, WR Fair, and M Burt
  JCO Jun 1 1996: 1765–1769. [Abstract] [PDF]  
Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer
  AV D'Amico, R Whittington, SB Malkowicz, D Schultz, M Schnall, JE Tomaszewski, and A Wein
  JCO Jun 1 1996: 1770–1777. [Abstract] [PDF]  
Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression
  R Kaempfer, L Gerez, H Farbstein, L Madar, O Hirschman, R Nussinovich, and A Shapiro
  JCO Jun 1 1996: 1778–1786. [Abstract] [PDF]  
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer
  S Welt, AM Scott, CR Divgi, NE Kemeny, RD Finn, F Daghighian, JS Germain, EC Richards, SM Larson, and LJ Old
  JCO Jun 1 1996: 1787–1797. [Abstract] [PDF]  
Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics
  B Yu, J Carrasquillo, D Milenic, Y Chung, P Perentesis, I Feuerestein, D Eggensperger, CF Qi, C Paik, J Reynolds, J Grem, G Curt, K Siler, J Schlom, and C Allegra
  JCO Jun 1 1996: 1798–1809. [Abstract] [PDF]  
Prognostic significance of bone marrow micrometastases in patients with gastric cancer
  KW Jauch, MM Heiss, U Gruetzner, I Funke, K Pantel, R Babic, HJ Eissner, G Riethmueller, and FW Schildberg
  JCO Jun 1 1996: 1810–1817. [Abstract] [PDF]  
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil- cisplatin plus intravenous fluorouracil
  D Kelsen, M Karpeh, G Schwartz, H Gerdes, C Lightdale, J Botet, G Lauers, D Klimstra, Y Huang, L Saltz, V Quan, and M Brennan
  JCO Jun 1 1996: 1818–1828. [Abstract] [PDF]  
Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors
  BG Taal, CA Hoefnagel, RA Valdes Olmos, H Boot, and JH Beijnen
  JCO Jun 1 1996: 1829–1838. [Abstract] [PDF]  
CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity
  MJ Alcorn, TL Holyoake, L Richmond, C Pearson, E Farrell, B Kyle, DJ Dunlop, E Fitzsimons, WP Steward, IB Pragnell, and IM Franklin
  JCO Jun 1 1996: 1839–1847. [Abstract] [PDF]  
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose
  N Avril, J Dose, F Janicke, S Bense, S Ziegler, C Laubenbacher, W Romer, H Pache, M Herz, B Allgayer, W Nathrath, H Graeff, and M Schwaiger
  JCO Jun 1 1996: 1848–1857. [Abstract] [PDF]  
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer
  JM Nabholtz, K Gelmon, M Bontenbal, M Spielmann, G Catimel, P Conte, U Klaassen, M Namer, J Bonneterre, P Fumoleau, and B Winograd
  JCO Jun 1 1996: 1858–1867. [Abstract] [PDF]  
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation
  KK Fields, GJ Elfenbein, WL Trudeau, JB Perkins, WE Janssen, and LC Moscinski
  JCO Jun 1 1996: 1868–1876. [Abstract] [PDF]  
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
  AD Seidman, D Hochhauser, M Gollub, B Edelman, TJ Yao, CA Hudis, P Francis, D Fennelly, TA Gilewski, ME Moynahan, V Currie, J Baselga, W Tong, M O'Donaghue, R Salvaggio, L Auguste, D Spriggs, and L Norton
  JCO Jun 1 1996: 1877–1884. [Abstract] [PDF]  
Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. International Breast Cancer Study Group
 
  JCO Jun 1 1996: 1885–1894. [Abstract] [PDF]  
Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group
  MA Bookman, WP McGuire, 3rd, D Kilpatrick, E Keenan, WM Hogan, SW Johnson, P O'Dwyer, E Rowinsky, HH Gallion, and RF Ozols
  JCO Jun 1 1996: 1895–1902. [Abstract] [PDF]  
Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer
  SP Joel, P Ellis, K O'Byrne, D Papamichael, M Hall, R Penson, S Nicholls, C O'Donnell, A Constantinou, J Woodhull, M Nicholson, I Smith, D Talbot, and M Slevin
  JCO Jun 1 1996: 1903–1912. [Abstract] [PDF]  
Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival
  JH Schiller, B Storer, J Berlin, J Wittenkeller, M Larson, L Pharo, M Larson, and W Berry
  JCO Jun 1 1996: 1913–1921. [Abstract] [PDF]  
Response of recurrent medulloblastoma to low-dose oral etoposide
  DM Ashley, L Meier, T Kerby, FM Zalduondo, HS Friedman, A Gajjar, L Kun, PK Duffner, S Smith, and D Longee
  JCO Jun 1 1996: 1922–1927. [Abstract] [PDF]  
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients
  P Colonna, JP Jais, B Desablens, JL Harousseau, J Briere, M Boasson, A Lemevel, P Casassus, PY Le Prise, F Guilhot, C Ghandour, F Lejeune, and JM Andrieu
  JCO Jun 1 1996: 1928–1935. [Abstract] [PDF]  
Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma
  S Ben-Haim, R Bar-Shalom, O Israel, N Haim, R Epelbaum, M Ben-Shachar, D Gaitini, GM Kolodny, and D Front
  JCO Jun 1 1996: 1936–1942. [Abstract] [PDF]  
Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases
  E Salloum, DL Cooper, G Howe, J Lacy, G Tallini, J Crouch, M Schultz, and J Murren
  JCO Jun 1 1996: 1943–1949. [Abstract] [PDF]  
Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy
  PA Johnstone, DC Rohde, SE Swartz, JE Fetter, and SD Wexner
  JCO Jun 1 1996: 1950–1956. [Abstract] [PDF]  
Update of recommendations for the use of hematopoietic colony- stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology
JCO Jun 1 1996: 1957–1960. [PDF]  
Tobacco control: reducing cancer incidence and saving lives. American Society of Clinical Oncology
 
  JCO Jun 1 1996: 1961–1963. [Abstract] [PDF]  
Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel
AA Miller, RC Lilenbaum, TJ Lynch, GL Rosner, MJ Ratain, MR Green, and RL Schilsky
JCO Jun 1 1996: 1964–1965. [PDF]  
Prostate interstitial implantation: half the solution
FA Critz
JCO Jun 1 1996: 1965a. [PDF]  
Prostate brachytherapy: importance of technique
JC Blasko, H Ragde, PD Grimm, and W Cavanagh
JCO Jun 1 1996: 1965b–1967. [PDF]  
Clinical prognostic factors in adjuvant melanoma trial
L Nathanson
JCO Jun 1 1996: 1967–1968. [PDF]  
Adjuvant interferon alfa-2b for high-risk melanoma
S Retsas
JCO Jun 1 1996: 1968–1969. [PDF]  
 
SPECIAL DEPARTMENTS Back

Erratum Back

Diffuse Small Noncleaved-Cell, Non-Burkitt's Lymphoma in Adults: A High-Grade Lymphoma Responsive to ProMACE-Based Combination Chemotherapy
  Don L. Longo, Patricia L. Duffey, Elaine S. Jaffe, Mark Raffeld, Susan M. Hubbard, Richard I. Fisher, Robert E. Wittes, Vincent T. DeVita, Jr, and Robert C. Young
  JCO Jun 1 1996: 1969. [Abstract] [PDF]  


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online